Inspiring Conversations at ADLM 2025: See You Next Year!

ADLM 2025 We were glad to participate in the ADLM 2025 Annual Meeting in Chicago! It was a pleasure chatting with so many industry partners and professionals — sharing insights on our raw materials & solutions and learning about your needs. The energy and engagement left us inspired! See you
Antibody / Antigen for Intestine Detection

Antibody / Antigen for Intestine Detection -HP/RV/EV71/FOB Intestinal diseases pose a growing global public health threat. According to the World Health Organization (WHO), approximately 1.7 billion people are infected with enterovirus annually, with rotavirus alone claiming the lives of over 215,000 children under the age of five each year. ✨Trusted by leading partners worldwide, Cnpair is committed to developing high-performance antibody pairs and antigens for intestinaldiseases, driving innovation in IVD. Helicobacter Pylori⦁ Natural antigens with broad epitope coverage⦁ High coincidence with the Urea Breath Test⦁ Compatible with multiple testingplatforms Rotavirus⦁ World-class performance⦁ High sensitivity⦁ No cross-reactivity with common diarrheal pathogens Enterovirus 71⦁ High accuracy⦁ Multi-platform compatibility⦁ No cross-reactivity with Coxsackievirus A16
Antibody / Antigen for Sexually Transmitted Diseases Detection —— HBV HCV HIV TP

Sexually transmitted diseases (STDs) continue to pose a significant global public health challenge. Cnpair is committed to enhancing blood safety and supporting effective disease control. Cnpair supplies premium HBV HCV HIV TP antigens antibodies. Cnpair STD Materials—— HBVHepatitis B VirusHCVHepatitis C VirusHIVHuman lmmunodeficiency VirusTPTreponema Pallidum Comprehensive CoverageOne-stop supply of detection
Discover what’s possible with Cnpair at ADLM 2025!
Antibody & Antigen for TB Detection

The Comprehensive Tuberculosis Guidelines issued by the World Health Organization (WHO) clearly recommend the tuberculin skin test (TST) and the interferon-gamma release assay (IGRA) as methods for detecting tuberculosis infection. Cnpair has introduced high-performance antibody pairs and antigens for TB detection including TB-IGRA, TB-LAM, etc., which demonstrating excellent sensitivity and
Antibody / Antigen for Gastric Cancer Detection

Cnpair supports the fight against gastric cancer by providing high-performance detection materials for Gastric Cancer Biomarkers: HP ( Helicobacter pylori), G17 (Gastrin-17), PGI (Pepsinogen I), and PGII (Pepsinogen II). Natural antigen Exceptionally high stability Cnpair’s HP Antigen retains its native conformation with all critical epitopes intact, ensuring high stability. In thermal acceleration
Newly Updated Antibody/Antigen for influenza A/B Detection

The latest data from FluNet shows that since January 2025, the global detection positive rate of influenza viruses has significantly increased, indicating an early flu season. This trend is particularly evident in temperate areas of the Northern Hemisphere, where influenza activity has gradually intensified. Cnpair has been dedicated to the
Ending TB epidemic is underway, Cnpair aiding to win the campaign

Tuberculosis(TB) is a chronic disease with strong infectiousness caused by Mycobacterium tuberculosis. It can infect various organs and systems of the human body, regardless of age, gender, race, occupation and region. Among all, pulmonary tuberculosis is the most common. It is the deadliest bacterial infection, which can cause over 14 million death per
Join Cnpair at CACLP 2025 in Hangzhou – Let’s Shape the Future of Diagnostics Together!

Join Cnpair at CACLP 2025 in Hangzhou– Let’s Shape the Future of Diagnostics Together! This spring, we’re excited to welcome you to CACLP 2025 in Hangzhou! Visit Cnpair at Booth 4-E0901 during March 22–24th to discover our latest innovations in IVD products and integrated services. Let’s explore new possibilities for